Neuropeptide gene polymorphisms and human behavioural disorders

被引:17
作者
Inui, A [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Clin Mol Med, Div Diabet Digest & Kidney Dis,Chuo Ku, Kobe, Hyogo 6500017, Japan
关键词
D O I
10.1038/nrd1252
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Energy homeostasis is controlled by a complex neuroendocrine system consisting of peripheral signals, such as leptin, and central signals, particularly neuropeptides. Animal experiments have demonstrated that neuropeptides present in the hypothalamus and other brain areas are important not only in the regulation of feeding and metabolism, but also in other neuroendocrine and behavioural functions. Knowledge about neuropeptides is increasingly used in the study of the pathophysiology of behavioural disorders. This review focuses on the influence of polymorphisms in genes encoding neuropeptides or neuropeptide receptors involved in diverse physiological processes. The identification of neuropeptide systems closely associated with human illnesses will aid the development of novel therapeutic strategies.
引用
收藏
页码:986 / 998
页数:13
相关论文
共 165 条
[41]   Genetics of two μ opioid receptor gene (OPRM1) exon I polymorphisms:: population studies, and allele frequencies in alcohol- and drug-dependent subjects [J].
Gelernter, J ;
Kranzler, H ;
Cubells, J .
MOLECULAR PSYCHIATRY, 1999, 4 (05) :476-483
[42]   A prepro-orexin gene polymorphism is associated with narcolepsy [J].
Gencik, M ;
Dahmen, N ;
Wieczorek, S ;
Kasten, M ;
Bierbrauer, J ;
Anghelescu, I ;
Szegedi, A ;
Saecker, AMM ;
Epplen, JT .
NEUROLOGY, 2001, 56 (01) :115-117
[43]  
Gonzalez-Gay MA, 2003, J RHEUMATOL, V30, P913
[44]  
GRUNDEMAR L, 1997, NEUROPEPTIDE Y DRUG, pR10
[45]   Identification and functional analysis of novel human melanocortin-4 receptor variants [J].
Gu, W ;
Tu, ZM ;
Kleyn, PW ;
Kissebah, A ;
Duprat, L ;
Lee, J ;
Chin, W ;
Maruti, S ;
Deng, NH ;
Fisher, SL ;
Franco, LS ;
Burn, P ;
Yagaloff, KA ;
Nathan, J ;
Heymsfield, S ;
Albu, J ;
Pi-Sunyer, FX ;
Allison, DB .
DIABETES, 1999, 48 (03) :635-639
[46]   A MISSENSE MUTATION IN THE GLUCAGON RECEPTOR GENE IS ASSOCIATED WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
HAGER, J ;
HANSEN, L ;
VAISSE, C ;
VIONNET, N ;
PHILIPPI, A ;
POLLER, W ;
VELHO, G ;
CARCASSI, C ;
CONTU, L ;
JULIER, C ;
CAMBIEN, F ;
PASSA, P ;
LATHROP, M ;
KINDSVOGEL, W ;
DEMENAIS, F ;
NISHIMURA, E ;
FROGUEL, P .
NATURE GENETICS, 1995, 9 (03) :299-304
[47]   No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder [J].
Hamilton, SP ;
Slager, SL ;
Helleby, L ;
Heiman, GA ;
Klein, DF ;
Hodge, SE ;
Weissman, MM ;
Fyer, AJ ;
Knowles, JA .
MOLECULAR PSYCHIATRY, 2001, 6 (01) :59-65
[48]   Function of the C-36 to T polymorphism in the human cholecystokinin gene promoter [J].
Hansen, TVO ;
Rehfeld, JF ;
Nielsen, FC .
MOLECULAR PSYCHIATRY, 2000, 5 (04) :443-447
[49]   A new genetic variant in the Sp1 binding Cis-element of cholecystokinin gene promoter region and relationship to alcoholism [J].
Harada, S ;
Okubo, T ;
Tsutsumi, M ;
Takase, S ;
Muramatsu, T .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 22 (03) :93S-96S
[50]  
Harrold J. A., 2003, Current Medicinal Chemistry - Central Nervous System Agents, V3, P141, DOI 10.2174/1568015033477785